Notable Upgrades: Sarepta Therapeutics (SRPT), SolarCity (SCTY), Pandora Media (P), LinkedIn (LNKD)

Analysts at Piper Jaffray are out with a report this morning upgrading shares of Sarepta Therapeutics, Inc. (SRPT) with a ‘Neutral’ from ‘Underweight’ rating.

In the past 52 weeks, shares of Cambridge, Massachusetts-based company have traded between a low of $8.00 and a high of $41.97 and are now at $21.49. Shares are down 25.80% year-over-year and 49.61% year-to-date.

SRPT

Analysts at Robert W. Baird upgraded their rating on the shares of SolarCity Corporation (SCTY). In a research note published on Thursday, the firm lifted the name with a ‘Outperform’ from ‘Neutral’ rating and set a 12-month base case estimate of $37 per share.

SolarCity recently traded at $22.88, a loss of $0.19 over Wednesday’s closing price. The name has a current market capitalization of $2.25 billion.

SCTY

Pandora Media, Inc. (P) was raised to ‘Buy’ from ‘Hold’ and it was given a $16 price target at Axiom Capital on Thursday.

Midway through trading Thursday, 4.14 million shares of Pandora Media Inc. have exchanged hands as compared to its average daily volume of 10.09 million shares. The stock ranged in a price between $12.00-$12.55 after having opened the day at $12.21 as compared to the previous trading day’s close of $11.81.

P

LinkedIn Corporation (LNKD) was upgraded to ‘Outperform’ from ‘Sector Perform’ with a $160 price target by RBC Capital Markets analysts on Thursday.

LNKD was up $2.06 at $135.91 in mid-day trade, moving within a 52-week range of $98.25 to $258.39. The name, valued at $18.16 billion, opened at $136.26.

LNKD

Be the first to comment

Leave a Reply

Your email address will not be published.


*